CBD & Social Anxiety Disorder Research Study
Researchers at New York University are partnering with individuals who get anxious in social situations to evaluate how treatment with cannabidiol (CBD) can help. Join our compensated study today!
Fast Facts
experience anxiety in social situations
Not diagnosed or in treatment for eating disorder, oCD, major depression, or substance use
18-45 years old
Compensation Provided
Conducted in new york
Study Background
Could CBD help with SAD?
Social Anxiety Disorder is a mental health disorder with specific core features, such as worry and anxiety about being judged, negatively evaluated, or rejected in social or performance situations. The purpose of this research study is to develop an understanding of how Cannabidiol (CBD) may work for the treatment of social anxiety disorder. Specifically, we want to understand how CBD targets core features of social anxiety, measured through experimental tasks and neuroimaging.
If you are someone who gets anxious in social situations, you may be eligible for this research study. Your participation may help researchers improve treatment approaches for social anxiety disorder. Advance research today and join our compensated study!
Study Background
Could CBD help with SAD?
Social Anxiety Disorder is a mental health disorder with specific core features, such as worry and anxiety about being judged, negatively evaluated, or rejected in social or performance situations. The purpose of this research study is to develop an understanding of how Cannabidiol (CBD) may work for the treatment of social anxiety disorder. Specifically, we want to understand how CBD targets core features of social anxiety, measured through experimental tasks and neuroimaging.
If you are someone who gets anxious in social situations, you may be eligible for this research study. Your participation may help researchers improve treatment approaches for social anxiety disorder. Advance research today and join our compensated study!
Additional Information
You may qualify for this study if you meet the following criteria.
Key Criteria:
- 18-45 years old
- Experience anxiety in social situations
- No major medical conditions
- Right-handed
- No current symptoms of eating disorders, OCD, substance use disorder, alcohol use disorder, or major depressive disorder
- No history of significant head injury or seizures
- No history of lung or renal failure
- No diagnosis of bipolar disorder or schizophrenia
- Not pregnant or breastfeeding
- Able to undergo an MRI
- Willing to use contraceptives (if applicable)
Participation in this study requires 5 study visits over the period of approximately one month.
- Step 1 of the study involves completing a brief phone interview.
- If preliminarily eligible after the phone-screening, step 2 of the study includes an in-person screening visit. If you agree to participate and sign the consent form, the visit will take 3 hours and involves a psychiatric history, as well as a blood draw, EKG, and urine sample to ensure that you are eligible for the study.
- If you are eligible for the study after screening, step 3 will occur in which you will be randomized to CBD or placebo for approximately 3 weeks. After being randomized over the phone, you will come in for a 3-hour long baseline visit. At this visit, you will begin taking the medication and undergo 2 blood draws.
- Approximately 2 weeks after completing the baseline, you will come in for visit 3, which lasts for 3 hours and involves 2 blood draws in addition to a stress task.
- 1 week after the completion of your 3rd visit, you will visit NYU for 2 consecutive days of experimental visits. This 2-day experimental session will include a 3 hour long visit with 2 blood draws and a learning task on the first day, followed by an hour-long fMRI scan on the second day.
